Ovarian cancer 2 ▲Current|Update|Genomics|CDC

Public Health Genomics Knowledge Base (v1.2)

Last Posted: Dec-23-2016 2PM

Last Posted: Dec 22, 2016

---

• Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
  Antonucci Ivana et al. Journal of human genetics 2016 Dec
• Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
  Dean Marleah et al. Health communication 2016 Dec 1-9
• BRCA mutation genetic testing implications in the United States.
  Bayraktar Soley et al. Breast (Edinburgh, Scotland) 2016 Dec 31224-232
• Clinical Cancer Genetics Disparities among Latinos.
  Cruz-Correa Marcia et al. Journal of genetic counseling 2016 Dec
• Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
  George Angela et al. Nature reviews. Clinical oncology 2016 Dec
• BRCA1 and BRCA2 mutation testing in Cyprus; a population based study.
  Loizidou M A et al. Clinical genetics 2016 Oct
• CDC Grand Rounds: Family History and Genomics as Tools for Cancer Prevention and Control.
  Rodriguez Juan L et al. MMWR. Morbidity and mortality weekly report 2016 Nov 65(46) 1291-1294
• PARP Inhibitors in Ovarian Cancer Treatment
  DR Spriggs et al,NEJM, November 30, 2016
• Tracking the dissemination of a culturally targeted brochure to promote awareness of hereditary breast and ovarian cancer among Black women.
  Scherr Courtney Lynam et al. Patient education and counseling 2016 Oct
• Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.
  Vergote Ignace et al. European journal of cancer (Oxford, England : 1990) 2016 Nov 69127-134
• Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands.
  Dommering Charlotte J et al. Familial cancer 2016 Nov
• Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
  Kne Alyssa et al. Journal of genetic counseling 2016 Nov
• Differences in survival for patients with familial and sporadic cancer.
  Lee Myeongjee et al. International journal of cancer 2016 Oct
• Do Ovarian Cancer Patients with a Family History of Cancer (Suspected BRCA1 or BRCA2 Mutation) Suffer Greater Chemotherapy Toxicity?
  Egloff Heidi et al. Cancer investigation 2016 Oct 1-5
• Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples.
  Badoer Cindy et al. Oncotarget 2016 Oct
• A Relational Approach to Genetic Counseling for Hereditary Breast and Ovarian Cancer.
  Forbes Shepherd Rowan et al. Journal of genetic counseling 2016 Oct

more

---

Most Recent Scientific Publications from Weekly Horizon Scans

From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

• Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
  Dean Marleah et al. Health communication 2016 Dec 1-9
• Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
  Antonucci Ivana et al. Journal of human genetics 2016 Dec
• Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
  George Angela et al. Nature reviews. Clinical oncology 2016 Dec
• Clinical Cancer Genetics Disparities among Latinos.
  Cruz-Correa Marcia et al. Journal of genetic counseling 2016 Dec
• BRCA mutation genetic testing implications in the United States.
  Bayraktar Soley et al. Breast (Edinburgh, Scotland) 2016 Dec 31224-232

more